Premier News

Our recent announcements and latest news

Also of Interest

April 1, 2024

Premier Research Expands Clinical Leadership Team with Addition of Milena Kanova-Petrova, MD, Global Head of General Medicine

MORRISVILLE, NC, April 1, 2024 – Premier Research is pleased to announce the addition of Dr. Milena Kanova-Petrova as Senior Vice President, Global Head of General Medicine. In this role, Dr. Kanova-Petrova will oversee strategic planning and project execution for all general medicine clinical operations inclusive of internal medicine, women’s health and dermatology. “Our customers…

March 11, 2024

Premier Research Appoints John Cargill as Chief Commercial Officer

MORRISVILLE, NC, March 11, 2024 – Premier Research is pleased to announce the appointment of John Cargill as its new Chief Commercial Officer. In this role, Mr. Cargill will be responsible for driving the organization’s commercial strategy including enhancements to the customer experience and supporting corporate growth. Mr. Cargill brings a wealth of experience and…

January 8, 2024

Premier Research and BioCentriq Enter a Strategic Partnership to Accelerate Pre‑IND Timelines and Clinical Translation of Innovative Cell Therapies

MORRISVILLE, NC and NEWARK, NJ, January 8, 2024 – Premier Research, a preeminent global clinical research, product development, and consulting company, and BioCentriq, a renowned Contract Development and Manufacturing Organization (CDMO), have entered a strategic partnership to revolutionize the pre-Investigational New Drug (IND) process and accelerate the clinical translation of novel cell therapy products. By…

November 20, 2023

Daré Bioscience and Premier Research Extend Strategic Partnership to Accelerate the Clinical Development of Daré’s Novel Women’s Health Programs

Partnership Aims to Advance Daré’s Reproductive Health Portfolio in a Timely and Capital Efficient Manner SAN DIEGO AND MORRISVILLE, N.C., November 20, 2023 (GLOBE NEWSWIRE) — Daré Bioscience, Inc. (NASDAQ: DARE), a leader in women’s health innovation, and Premier Research International, LLC, a global clinical research, product development, and consulting company, today announced that the companies extended their partnership agreement under which…

November 6, 2023

Premier Research Adds to Deep Oncology Expertise Naming Elaina N. Haeuber SVP, Oncology

MORRISVILLE, N.C., November 6, 2023 — Premier Research announced today the addition of Elaina N. Haeuber, M.S. as Senior Vice President, Oncology.  Women now lead all therapeutic specialty teams at Premier Research. “We continue to expand and deepen our oncology team as these studies become increasingly complex and the clinical trial pipeline continues to grow,”…

August 15, 2023

New Hires Strengthen Premier Research’s Clinical Development Services, Enhancing Therapeutic and Risk-Based Strategy

MORRISVILLE, N.C., August 15, 2023 — Premier Research has strategically expanded its Clinical Development Services team to enhance therapeutic strategy, special patient population expertise, and risk-based clinical development service offerings for biotech and medtech sponsors. “With the patient experience at the forefront, our team is equipped to analyze study-specific challenges and provide tailored strategies to…

June 15, 2023

Premier Research Celebrated at 2023 CRO Leadership Awards

MORRISVILLE, N.C., June 15, 2023 — Premier Research, whose mission is to help the most innovative biotech and medtech companies take their best ideas from concept to commercialization, was honored to be recognized at the 2023 CRO Leadership Awards as a top outsourcing partner. The organization received awards for Compatibility, Expertise, and Reliability in both…

April 17, 2023

Premier Research Fortifies Cell and Gene Therapy Leadership Team, Strengthening End-to-End Capabilities in Complex Asset Development

Cell and Gene Therapy Expert Dr. Kenneth Ndugga-Kabuye to Lead Clinical Strategy With Collaboration From Operations, CMC and Regulatory Experts MORRISVILLE, N.C., April 17, 2023– Premier Research announced today the addition of Kenneth Ndugga-Kabuye, M.D., FACMG, as VP, Cell & Gene Therapy to the strategic Cell & Gene Therapy (CGT) Leadership Team. Ndugga-Kabuye joins experts…